CliffBio
small molecule

MORPHINE SULFATE

MORPHINE SULFATE

Loss of exclusivity—loss of exclusivity
CompanySTRIDES PHARMA INTERNATIONAL AG

Drug detail

Brand nameMORPHINE SULFATE
Active ingredientMORPHINE SULFATE
Strength30MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2011
Marketing statusDISCN

More from STRIDES PHARMA INTERNATIONAL AG

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

MORPHINE SULFATE patent cliff — loss of exclusivity — | CliffBio